Personal Information
Organization / Workplace
Istanbul Turkey
Industry
Medical / Health Care / Pharmaceuticals
Website
www.trustlifeventures.com/
About
Turkey's National Health Technologies-TRUSTLIFE” was established to bring together innovative treatment targets and drug candidates, determined by the research carried out by academicians, R&D institutions, and Start-Ups in our country, with the investor and to implement them. TRUSTLIFE is Turkey's first and only health technologies platform and is a Venture Capital Investment Fund (GSYF) approved by the Capital Markets Board (CMB). It has the necessary organization to support these projects in a way that covers all financial, managerial, and technical sub-items.
Tags
adil mardinoglu
trustlife
hasan turkez
patent
systems biology
drugdiscovery
glioblastoma
health
treatment
trustlifelabs
alzheimer’s disease
carcinoma
medicine
trustlifeventures
biotechnology
drug repositioning
cancer
drug development
nafld
adenocarcinoma
biology
ccrcc
dementia
pklr
prostatecancer
gbm
liver pyruvate kinase
drug
ai in healthcare
disease
parbendazole
gene co-expression network
molecular docking
protein
hcc
lung
bortezomip
jnk inhibition
personalized medicine
pharmaceutical r&d
life sciences
cancerresearch
cancertreatment
alzheimersresearch
cell-permeable allosteric
healthcare innovation
investment models
future of medicine
bülent denkdemir
technology
ai
treatment of lung
dietary sucrose
4
5
6
sarcopenia
cancertherapeutics
7-tetrahydrobenzo[b]thio
7-tetrahydrobenzo
thiophene-3
carbonitrile derivatives
prostatecancertreatment
genetherapy
medicalinnovation
n-alkylation/cuaac synthesis
x-ray crystallography
dft calculations
oncologyinnovation
precisionmedicine
adme predictions
therapeutictargetgene
multi-omics data
genome-scale metabolic models
energy metabolism
reporter metabolite analysis
genome-scale metabolic model
gems
metabolic models
genome-scale
pharmacotherapy
biomedicine
trustlife mafld; allosteric pkl inhibition; tag co
pyruvate kinase
neuroinnovation
medicalresearch
molstruc
teknoloji
venture capital
multi-tissue network analysis
hirschfield surface analysis
synthesis
x-ray
dft
docking
anti-carcinogenic drugs
glutaminase
profile-based computational dr
adil mardino˘glu
sar studies
c
urolithin
allosteric inhibitors
circadian rhythms
target chemotherapy
co-expression network
klinik öncesi araştırmalar
omik teknolojiler
hücresel toksisite
ilaç güvenliği
yearly
annual
2024
report
hepatic metabolism
inflammation
network analysis
fatty liver
metabolic dysfunction
mafld
essam hanashalshahaby
gizem bati-ayaz
betul yasin
sevval dik
yunus kesgun
sana saffour
jihane akachar
healthtech
yapay zeka
çoklu omik veri
ar-ge
healttech
future of pharma
clinical trials
precision medicine
pharmaceutical innovation
artificial intelligence
toxicology
genotoxicity
preclinical studies
omics technologies
cellular toxicology
drug safety
kişiselleştirilmiş tıp
sistem biyolojisi
nörotoksisite
genotoksisite
toksikoloji
hepatocellular
targeted therapy
clear cell rcc
oncology
cancer treatment
tg-101209
caki-1
bub1b
structure-activity
drug design
therapeutic agent
extracellular matrix
glycosaminoglycans
co-expression
survival
novel drug
molecule
translational medicine
drug repurposing
differential expression
co-expression network analys
nadeem abad
shafeek buhlak
anti-cancer
vegfa–vegfr2 pathway
molecular dynamics
therapeutic efficacy
4-dihydroquinolin-2(1h)-one
3
multiforme
prostat kanseri
bileşik
tedavi
kanser tedavisi
pankreas
in vitro
lung cancer
luad
adeno
fatty liver disease
liver
pharmaceutical
healthcare
See more
Presentations
(4)Documents
(41)Personal Information
Organization / Workplace
Istanbul Turkey
Industry
Medical / Health Care / Pharmaceuticals
Website
www.trustlifeventures.com/
About
Turkey's National Health Technologies-TRUSTLIFE” was established to bring together innovative treatment targets and drug candidates, determined by the research carried out by academicians, R&D institutions, and Start-Ups in our country, with the investor and to implement them. TRUSTLIFE is Turkey's first and only health technologies platform and is a Venture Capital Investment Fund (GSYF) approved by the Capital Markets Board (CMB). It has the necessary organization to support these projects in a way that covers all financial, managerial, and technical sub-items.
Tags
adil mardinoglu
trustlife
hasan turkez
patent
systems biology
drugdiscovery
glioblastoma
health
treatment
trustlifelabs
alzheimer’s disease
carcinoma
medicine
trustlifeventures
biotechnology
drug repositioning
cancer
drug development
nafld
adenocarcinoma
biology
ccrcc
dementia
pklr
prostatecancer
gbm
liver pyruvate kinase
drug
ai in healthcare
disease
parbendazole
gene co-expression network
molecular docking
protein
hcc
lung
bortezomip
jnk inhibition
personalized medicine
pharmaceutical r&d
life sciences
cancerresearch
cancertreatment
alzheimersresearch
cell-permeable allosteric
healthcare innovation
investment models
future of medicine
bülent denkdemir
technology
ai
treatment of lung
dietary sucrose
4
5
6
sarcopenia
cancertherapeutics
7-tetrahydrobenzo[b]thio
7-tetrahydrobenzo
thiophene-3
carbonitrile derivatives
prostatecancertreatment
genetherapy
medicalinnovation
n-alkylation/cuaac synthesis
x-ray crystallography
dft calculations
oncologyinnovation
precisionmedicine
adme predictions
therapeutictargetgene
multi-omics data
genome-scale metabolic models
energy metabolism
reporter metabolite analysis
genome-scale metabolic model
gems
metabolic models
genome-scale
pharmacotherapy
biomedicine
trustlife mafld; allosteric pkl inhibition; tag co
pyruvate kinase
neuroinnovation
medicalresearch
molstruc
teknoloji
venture capital
multi-tissue network analysis
hirschfield surface analysis
synthesis
x-ray
dft
docking
anti-carcinogenic drugs
glutaminase
profile-based computational dr
adil mardino˘glu
sar studies
c
urolithin
allosteric inhibitors
circadian rhythms
target chemotherapy
co-expression network
klinik öncesi araştırmalar
omik teknolojiler
hücresel toksisite
ilaç güvenliği
yearly
annual
2024
report
hepatic metabolism
inflammation
network analysis
fatty liver
metabolic dysfunction
mafld
essam hanashalshahaby
gizem bati-ayaz
betul yasin
sevval dik
yunus kesgun
sana saffour
jihane akachar
healthtech
yapay zeka
çoklu omik veri
ar-ge
healttech
future of pharma
clinical trials
precision medicine
pharmaceutical innovation
artificial intelligence
toxicology
genotoxicity
preclinical studies
omics technologies
cellular toxicology
drug safety
kişiselleştirilmiş tıp
sistem biyolojisi
nörotoksisite
genotoksisite
toksikoloji
hepatocellular
targeted therapy
clear cell rcc
oncology
cancer treatment
tg-101209
caki-1
bub1b
structure-activity
drug design
therapeutic agent
extracellular matrix
glycosaminoglycans
co-expression
survival
novel drug
molecule
translational medicine
drug repurposing
differential expression
co-expression network analys
nadeem abad
shafeek buhlak
anti-cancer
vegfa–vegfr2 pathway
molecular dynamics
therapeutic efficacy
4-dihydroquinolin-2(1h)-one
3
multiforme
prostat kanseri
bileşik
tedavi
kanser tedavisi
pankreas
in vitro
lung cancer
luad
adeno
fatty liver disease
liver
pharmaceutical
healthcare
See more